GLP-1 agonist drug prescriptions surge 600% in U.S
Summary: Prescriptions for GLP-1 agonist drugs in the U.S. for weight loss and diabetes among ages 12-25 surged 594.4% from 2020 to 2023, with young women and girls seeing the largest increase. The study, published in JAMA, analyzed data from over 93% of U.S. retail pharmacies. Obesity and type 2 diabetes are rising among young people, with predictions of a 673% increase in type 2 diabetes cases by 2060.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings